Showing results (101-110 of 312) with videos related to
Sort By:
Pageof 32
Journal of Cancer Research and Clinical Oncology|January 1, 1988
Growth requirements, growth factor responsiveness, and growth factor secretion of three human embryonal carcinoma cell linesW Verbeek, C Bokemeyer, H Falk, et al.Investigational New Drugs|January 1, 1997
Pre-clinical activity of taxol in non-seminomatous germ cell tumor cell lines and nude mouse xenograftsT A Dunn, V Grünwald, C Bokemeyer, et al.Deutsche Medizinische Wochenschrift (1946)|October 1, 2014
[Current treatment concepts for castration resistant prostate cancer]G von Amsberg, P Stroelin, C Bokemeyer, et al.Andrology|March 30, 2019
Epigenetic treatment combinations to effectively target cisplatin-resistant germ cell tumors: past, present, and future considerationsC Oing, M A Skowron, C Bokemeyer, et al.The Journal of Urology|November 1, 1993
Familial occurrence of Leydig cell tumors: a report of a case in a father and his adult sonC Bokemeyer, M Kuczyk, P Schöffski, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|July 25, 2015
The impact of social factors on outcomes in patients with bleeding disordersK Holstein, S von Mackensen, C Bokemeyer, et al.World Journal of Urology|January 1, 1994
Treatment intensification in disseminated germ-cell tumorsJ Beyer, C Bokemeyer, H J Schmoll, et al.Der Urologe. Ausg. A|June 29, 2021
[Diagnosis and treatment of rare testicular tumors using the example of malignant mesothelioma of the tunica vaginalis testis and Sertoli cell tumors]G von Amsberg, M Sehovic, M Hartmann, et al.Anti-Cancer Drugs|June 19, 2004
Hypersensitivity pneumonitis associated with the use of trofosfamideH-G Kopp, L Kanz, J T HartmannJournal of Cancer Research and Clinical Oncology|January 1, 1987
Targeting of neoglycoprotein-drug conjugates to cultured human embryonal carcinoma cellsH J Gabius, C Bokemeyer, T Hellmann, et al.Pageof 32